Twist Bioscience Corporation TWST Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Gross margin | 50.7%+8.1pp | 42.6%+6.0pp | 36.6%-4.8pp | 41.4%+2.3pp | |
| Operating margin | -36.2%+34.4pp | -70.6%+18.0pp | -88.6%+26.7pp | -115.3%+0.1pp | |
| Net margin | -20.6%+46.1pp | -66.7%+16.8pp | -83.5%+23.5pp | -107%+7.9pp | |
| Returns | |||||
| Return on equity | -16.4%+21.7pp | -38.1%-9.1pp | -29%+2.8pp | -31.8%+1.4pp | |
| Return on invested capital | -38.6%+19.8pp | -58.4%-11.8pp | -46.6%+22.4pp | -69%-1.8pp | |
| Efficiency | |||||
| Asset turnover | 0.6×+0.1× | 0.5×+0.2× | 0.3×0.0× | 0.2×0.0× | |
| Liquidity | |||||
| Current ratio | 3.6×-1.2× | 4.9×-0.9× | 5.8×-0.8× | 6.6×-2.1× | |
| Leverage | |||||
| Debt-to-equity | 0.2×0.0× | 0.2×0.0× | 0.2×0.0× | 0.1×0.0× | |
| Per Share | |||||
| Book value per share | $7.91-2.9% | $8.15-25.7% | $10.96-25.2% | $14.65+21.7% | |
| Valuation | |||||
| Market capitalization | $1.7B-35.3% | $2.63B+126% | $1.16B-41.6% | $1.99B-62.6% | |
| Price / sales | 4.5×-3.9× | 8.4×+3.7× | 4.7×-5.0× | 9.8×-30.4× | |
| Price / book | 3.6×-2.0× | 5.6×+3.7× | 1.9×-0.7× | 2.5×-6.6× |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What are Twist Bioscience Corporation's profit margins?
- Twist Bioscience Corporation (TWST) runs a 52.1% gross margin and a -33.9% operating margin, with a -19.8% net margin.
- Where do Twist Bioscience Corporation's ratios come from?
- Every ratio is computed from Twist Bioscience Corporation's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.
